Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 9/2020

Inhalt (24 Artikel)

Open Access Review – Cancer Research

The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review

Yu-Lin Lin, Ru Ma, Yan Li

Open Access Original Article – Cancer Research

Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)

Yao Ye, Lin Peng, Aurelia Vattai, Eileen Deuster, Christina Kuhn, Christian Dannecker, Sven Mahner, Udo Jeschke, Viktoria von Schönfeldt, Helene H. Heidegger

Original Article – Cancer Research

Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target

Jiang Chang, Zeng-Shan Liu, De-Feng Song, Meng Li, Song Zhang, Ke Zhao, Yu-Ting Guan, Hong-Lin Ren, Yan-Song Li, Yu Zhou, Xi-Lin Liu, Shi-Ying Lu, Pan Hu

Original Article – Cancer Research

The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation

Alan Cheuk Keong Yaw, Elaine Wan Ling Chan, Jeremy Kean Yi Yap, Chun Wai Mai

Original Article – Cancer Research

Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion

Jun Xie, Xian Zhang, Song Hu, Wan-Da Peng, Bin Xu, Yan Li, Su-Juan Zhang, Qing Li, Chong Li

Original Article – Cancer Research

Bone marrow adipocytes enhance osteolytic bone destruction by activating 1q21.3(S100A7/8/9-IL6R)-TLR4 pathway in lung cancer

Guojing Luo, Mengjia Tang, Qian Zhao, Lingyun Lu, Ying Xie, Yujue Li, Chang Liu, Li Tian, Xiang Chen, Xijie Yu

Original Article – Cancer Research

Targeting glycolysis with 2-deoxy-d-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors

Adrian Georg Simon, Laura Kristin Esser, Jörg Ellinger, Vittorio Branchi, Yuri Tolkach, Stefan Müller, Manuel Ritter, Glen Kristiansen, Michael Helmut Muders, Thomas Mayr, Marieta Ioana Toma

Original Article – Cancer Research

Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma

Davide Franceschini, Luca Cozzi, Mauro Loi, Ciro Franzese, Giacomo Reggiori, Pietro Mancosu, Alessandro Clivio, Antonella Fogliata, Marta Scorsetti

Original Article – Cancer Research

Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing

Xiaoyun Zhou, Xiaohui Xu, Zhenhuan Tian, Wang-Yang Xu, Yushang Cui

Original Article – Cancer Research

Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity

Ciro Franzese, Marco Lorenzo Bonu, Tiziana Comito, Elena Clerici, Mauro Loi, Pierina Navarria, Davide Franceschini, Tiziana Pressiani, Lorenza Rimassa, Marta Scorsetti

Open Access Original Article – Cancer Research

Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma

Jie Liu, Xiao Yang, Liang Zhang, Bo Yang, Wen Rao, Mengxia Li, Nan Dai, Yuxin Yang, Chengyuan Qian, Lei Zhang, Hualiang Xiao, Dong Wang

Original Article – Cancer Research

PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Dario Zerini, Barbara Alicja Jereczek-Fossa, Antonella Ciabattoni, Alessandra Mirri, Filippo Bertoni, Sergio Fersino, Giuseppe D’Agostino, Frank Lohr, Gianluca Mortellaro, Luca Triggiani, Giulia Marvaso, Matteo Pepa, Francesco Cuccia, Filippo Alongi

Open Access Original Article – Cancer Research

Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma

Florian Gebauer, Max Krämer, Christiane Bruns, Hans A. Schlößer, Martin Thelen, Philipp Lohneis, Wolfgang Schröder, Thomas Zander, Hakan Alakus, Reinhard Buettner, Heike Loeser, Alexander Quaas

Review – Clinical Oncology

Artificial intelligence in gastric cancer: a systematic review

Peng Jin, Xiaoyan Ji, Wenzhe Kang, Yang Li, Hao Liu, Fuhai Ma, Shuai Ma, Haitao Hu, Weikun Li, Yantao Tian

Original Article – Clinical Oncology

Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases

Luca Nicosia, Francesco Cuccia, Rosario Mazzola, Vanessa Figlia, Niccolò Giaj-Levra, Francesco Ricchetti, Michele Rigo, Marco Bonù, Stefanie Corradini, Maria Tolia, Filippo Alongi

Original Article – Clinical Oncology

Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis

Jixian Liu, Guangxian Mao, Yingmei Li, Lili Tao, Weifeng Wang, Xuxing Peng, Junbin Wang, Xiaoqiang Li, Xinyu Luan, Ruixing Luo, Tanxiao Huang, Jing Zhang, Mengmeng Xu, Shifu Chen, Da Wu

Original Article – Clinical Oncology

Feasibility and safety of 1.5 T MR-guided and daily adapted abdominal-pelvic SBRT for elderly cancer patients: geriatric assessment tools and preliminary patient-reported outcomes

Rosario Mazzola, Vanessa Figlia, Michele Rigo, Francesco Cuccia, Francesco Ricchetti, Niccolò Giaj-Levra, Luca Nicosia, Claudio Vitale, Gianluisa Sicignano, Antonio De Simone, Stefania Naccarato, Ruggero Ruggieri, Filippo Alongi

Original Article – Clinical Oncology

Conversion surgery after cetuximab or bevacizumab plus FOLFIRI chemotherapy in colorectal cancer patients with liver- and/or lung-limited metastases

Sang-A Kim, Ji-Won Kim, Koung Jin Suh, Won Chang, Jin Won Kim, Heung-Kwon Oh, Jai Young Cho, Duck-Woo Kim, Sukki Cho, Jee Hyun Kim, Kwhanmien Kim, Sung-Bum Kang, Sanghoon Jheon, Keun-Wook Lee

Original Article – Clinical Oncology

Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy

Yang Zhang, Chaoqiang Deng, Xiao Ma, Zhendong Gao, Shengping Wang, Qiang Zheng, Guozhan Xia, Zhexu Wen, Han Han, Fangqiu Fu, Quan Liu, Hong Hu, Yuan Li, Kwok-Kin Wong, Haiquan Chen

Open Access Original Article – Clinical Oncology

Recommendations on complementary and alternative medicine within S3 guidelines in oncology: systematic quality assessment of underlying methodology

Sabine Kutschan, Maren Freuding, Christian Keinki, Jutta Huebner

Open Access Original Article – Clinical Oncology

Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes

Yuxin Mu, Xuezhi Hao, Puyuan Xing, Xingsheng Hu, Yan Wang, Teng Li, Jinyao Zhang, Ziyi Xu, Junling Li

Letter to the Editor

MYC/BCL2/BCL6 triple hit lymphoma of the pericardium: a case report and review of the literature

A. Efstathopoulou, M. Ghielmini, E . Zucca

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.